- Home
- Brussels
- Company regulated news
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
24 Jan 2023 17:35 CET |
AZELIS GROUP NV | Azelis Strengthens Its Presence in Israel Through the Acquisition of Lidorr Elements | - | Mergers, Acquiqitions, Transferts |
24 Jan 2023 11:31 CET |
CARE PROPERTY INVEST | Publication du nouveau dénominateur après l’augmentation de capital | - | Commercial operations |
24 Jan 2023 11:31 CET |
CARE PROPERTY INVEST | Publication of the new denominator following the capital increase | - | Commercial operations |
24 Jan 2023 11:31 CET |
CARE PROPERTY INVEST | Openbaarmaking van de nieuwe noemer na de kapitaalverhoging | - | Commercial operations |
24 Jan 2023 07:00 CET |
HYLORIS | Hyloris annonce un partenariat commercial pour Maxigesic® IV dans 9 pays européens | - | Alliances and agreements |
24 Jan 2023 07:00 CET |
HYLORIS | Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European Countries | - | Alliances and agreements |
23 Jan 2023 18:12 CET |
GBL | GBL - Transacties op GBL-aandelen 23-01-2023 | - | Other financial transaction |
23 Jan 2023 18:11 CET |
GBL | GBL - Transactions sur actions propres 23-01-2023 | - | Other financial transaction |
23 Jan 2023 18:09 CET |
GBL | GBL - Transactions on GBL shares 23-01-2023 | - | Other financial transaction |
23 Jan 2023 17:40 CET |
KBC ANCORA ord | Update inkoopprogramma KBC Ancora tot 20 januari 2023 | - | Other subject |
23 Jan 2023 17:40 CET |
KBC ANCORA ord | Update on share repurchase program KBC Ancora until 20 January 2023 | - | Other subject |
23 Jan 2023 17:40 CET |
KBC ANCORA ord | Mise à jour du programme de rachat d’actions propres KBC Ancora jusqu’au 20 janvier 2023 | - | Other subject |
23 Jan 2023 08:38 CET |
TITAN CEMENT | Programme de rachats d'actions | - | Other subject |
23 Jan 2023 08:37 CET |
TITAN CEMENT | Share buyback programme | - | Other subject |
23 Jan 2023 08:00 CET |
EURONAV | Kennisgeving betreffende een 13D filing door Famatown Finance Limited | - | Other subject |
23 Jan 2023 08:00 CET |
EURONAV | Disclosure regarding a 13D Filing by Famatown Finance Limited | - | Other subject |
23 Jan 2023 07:25 CET |
JENSEN-GROUP | Update: Inkoop eigen aandelen | - | Other subject |
23 Jan 2023 07:24 CET |
JENSEN-GROUP | Update: share buy back | - | Other subject |
20 Jan 2023 08:15 CET |
BEKAERT | Bekaert - Update over het Inkoop van Eigen Aandelen Programma en de Liquiditeitsovereenkomst | 55102010 Iron and Steel | Legal |
20 Jan 2023 08:15 CET |
BEKAERT | Bekaert - Update on the Share Buyback Program and the Liquidity Agreement | 55102010 Iron and Steel | Legal |
20 Jan 2023 08:15 CET |
BEKAERT | Bekaert - Mise à jour relative au Programme de Rachat d’Actions et au Contrat de Liquidité | 55102010 Iron and Steel | Legal |
20 Jan 2023 08:00 CET |
EURONAV | Euronav to announce Q4 2022 results on Thursday 2 February 2023 | 50206030 Marine Transportation | Other subject |
20 Jan 2023 08:00 CET |
EURONAV | Euronav kondigt Q4 2022 resultaten aan op donderdag 2 februari 2023 | 50206030 Marine Transportation | Other subject |
20 Jan 2023 07:35 CET |
DMS IMAGING | 2022 revenue: EUR 35.3 m - 2023 targets and perspectives | 20103010 Biotechnology | Sales, Income |
20 Jan 2023 07:35 CET |
DMS IMAGING | Chiffre d'affaires 2022 : 35,3 M EUR - Objectifs 2023 | 20103010 Biotechnology | Sales, Income |
20 Jan 2023 07:00 CET |
MDXHEALTH | MDxHealth communique des informations financières actualisées et supplémentaires liées à l'acquisition du test GPS | 20103010 Biotechnology | Commercial results |
20 Jan 2023 07:00 CET |
HYLORIS | Hyloris Pharmaceuticals élargit son portefeuille avec un produit candidat pour le traitement de la déficience minérale dans le sang (l’hypophosphatémie) | 20103010 Biotechnology | News contracts |
20 Jan 2023 07:00 CET |
MDXHEALTH | MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS Test | 20103010 Biotechnology | Commercial results |
20 Jan 2023 07:00 CET |
HYLORIS | Hyloris Pharmaceuticals expands its Pipeline with a Product Candidate for a Mineral Deficiency in the Blood (hypophosphatemia) | 20103010 Biotechnology | News contracts |
19 Jan 2023 18:00 CET |
VAN DE VELDE | VAN DE VELDE : Acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
19 Jan 2023 18:00 CET |
VAN DE VELDE | VAN DE VELDE : Inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
19 Jan 2023 17:50 CET |
CENERGY | Hellenic Cables lance d'importants investissements pour répondre à la demande croissante en matière d'électrification et de transition énergétique | 50202010 Electrical Components | Commercial operations |
19 Jan 2023 17:49 CET |
CENERGY | Hellenic Cables initiates major investments to gear up for growing demand in Electrification and Energy Transition | 50202010 Electrical Components | Commercial operations |
18 Jan 2023 17:45 CET |
AZELIS GROUP NV | Azelis Group NV: Transparency Notification | 55201000 Chemicals: Diversified | Other subject |
18 Jan 2023 17:45 CET |
AZELIS GROUP NV | Azelis Group NV: Transparantiekennisgeving | 55201000 Chemicals: Diversified | Other subject |
18 Jan 2023 09:03 CET |
SHURGARD | 20230116 Shurgard obtains building permit in Berlin | 35101010 Real Estate Holding and Development | Other subject |
18 Jan 2023 08:00 CET |
EURONAV | Euronav dient verzoek tot spoedarbitrage in | 50206030 Marine Transportation | Other subject |
18 Jan 2023 08:00 CET |
EURONAV | Euronav files request for emergency arbitration | 50206030 Marine Transportation | Other subject |
18 Jan 2023 07:00 CET |
BIOSENIC | BioSenic appoints Dr Carole Nicco as Chief Scientific Officer | 20103010 Biotechnology | Corporate life |
18 Jan 2023 07:00 CET |
BIOSENIC | BioSenic nomme Dr Carole Nicco, en qualité de Directrice Scientifique | 20103010 Biotechnology | Corporate life |
17 Jan 2023 17:40 CET |
BIOCARTIS | Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY OBJECTIVES | 20101025 Health Services | Commercial results |
17 Jan 2023 17:40 CET |
BIOCARTIS | Persbericht Biocartis Group NV: BIOCARTIS BEHAALT BELANGRIJKSTE 2022 DOELSTELLINGEN | 20101025 Health Services | Commercial results |
17 Jan 2023 08:00 CET |
EURONAV | Request to convene General Shareholders’ Meeting by CMB | 50206030 Marine Transportation | Other subject |
17 Jan 2023 08:00 CET |
EURONAV | VERZOEK TOT BIJEENROEPING ALGEMENE VERGADERING VAN AANDEELHOUDERS DOOR CMB | 50206030 Marine Transportation | Other subject |
16 Jan 2023 19:30 CET |
ARGENX SE | argenx Announces Extraordinary General Meeting of Shareholders on February 27, 2023 to Appoint Steve Krognes as Non-Executive Director | 20103010 Biotechnology | Other subject |
16 Jan 2023 18:08 CET |
GBL | GBL - Transacties op GBL-aandelen 16-01-2023 | 30202000 Diversified Financial Services | Other financial transaction |
16 Jan 2023 18:07 CET |
GBL | GBL - Transactions sur actions propres 16-01-2023 | 30202000 Diversified Financial Services | Other financial transaction |
16 Jan 2023 18:05 CET |
GBL | GBL - Transactions on GBL shares 16-01-2023 | 30202000 Diversified Financial Services | Other financial transaction |
16 Jan 2023 17:40 CET |
BIOCARTIS | Persbericht Biocartis Group NV: Voltooiing van alomvattende herkapitalisatie transacties | 20101025 Health Services | Corporate life |
16 Jan 2023 17:40 CET |
KBC ANCORA ord | Update inkoopprogramma KBC Ancora tot 13 januari 2023 | 30101010 Banks | Other subject |